# Insmed Incorporated (NASDAQ: INSM), Bridgewater, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/insmed-incorporated/2b1442ae-b800-4f95-90a5-f0891d7adc79

> Inspection records and compliance data for Insmed Incorporated in Bridgewater, New Jersey. 3 FDA inspections on record, 1 Form 483, last inspected April 03, 2025. Publicly traded as NASDAQ: INSM.

---

## Details

- Name: Insmed Incorporated
- FEI Number: 3001236995
- Address Line 1: 700 Us Highway 202/206
- City: Bridgewater
- State: New Jersey
- Zip Code: 08807
- Country Name: United States
- Address: 700 Us Highway 202/206, Bridgewater, New Jersey 08807, United States
- Country: United States

## Stock

- Stock ticker: INSM
- Exchange: NASDAQ
- Share price: $118.07
- Market cap: $25.9B
- Price as of: November 13, 2026

## Related Documents

- [483 - Insmed Incorporated - 2025-04-03](https://www.keypedia.com/records/483/insmed-incorporated/d48d0d07-21b7-4991-863b-e1354589f4ec) — source: FDA, date: April 3, 2025
- [FDA Inspection 1265807 - Insmed Incorporated - 2025-04-03](https://www.keypedia.com/records/fda_inspections/insmed-incorporated/90f09f91-6843-4e90-8447-936e9e5eeb85) — classification: No Action Indicated (NAI), source: FDA, date: April 3, 2025
- FDA Inspection 1265807 - Insmed Incorporated - 2025-04-03 — classification: No Action Indicated (NAI), source: FDA, date: April 3, 2025
- [FDA Inspection 1147825 - Insmed Incorporated - 2021-08-03](https://www.keypedia.com/records/fda_inspections/insmed-incorporated/4f6c21f3-fd67-4053-808d-9b781e65e211) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 3, 2021
- FDA Inspection 556842 - Insmed Incorporated - 2009-01-21 — classification: No Action Indicated (NAI), source: FDA, date: January 21, 2009

## Related Companies

- [Pierre Fabre Pharmaceuticals, Inc.](https://www.keypedia.com/companies/pierre-fabre-pharmaceuticals-inc/ee0282e8-44f7-43c1-b3d5-fdc0c75129dc)
- [GUERBET LLC](https://www.keypedia.com/companies/guerbet-llc/415cb194-2519-4a28-82b2-e5d8846487d0)
- [Ajanta Pharma USA Inc](https://www.keypedia.com/companies/ajanta-pharma-usa-inc/fb94ebd3-ce80-4426-8f91-9f82716e5ea6)
- [BeOne Medicines USA, Inc.](https://www.keypedia.com/companies/beone-medicines-usa-inc/c0db89d5-6a53-40bc-8d3f-3c603e17a11d)
- [Daiichi Sankyo, Inc.](https://www.keypedia.com/companies/daiichi-sankyo-inc/fd789c74-6b2b-43fb-800d-326eceeb1aea)
- [Mark V. DiBuono, MD](https://www.keypedia.com/companies/mark-v-dibuono-md/d4a83632-9740-40b5-b692-f22b9766a077)
- [Recsei Laboratories, LLC](https://www.keypedia.com/companies/recsei-laboratories-llc/fbab5cb9-ce7e-4e4a-9087-da02c1babf5a)
- [Sky Systems Co., Inc.](https://www.keypedia.com/companies/sky-systems-co-inc/4dd1de38-814a-40df-9ea2-ea334abecb31)
- [DOH Central Pharmacy](https://www.keypedia.com/companies/doh-central-pharmacy/85e1d2b3-dd22-4cb0-91fe-dbf0dae1c156)
- [Patheon API Services Inc.](https://www.keypedia.com/companies/patheon-api-services-inc/cb150693-202d-4af5-8bfb-acc6807d16a5)

## Related Officers

- [investigator](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)